Abstract
With 296 million cases estimated worldwide, chronic hepatitis B virus (HBV) infection is the most common risk factor for hepatocellular carcinoma (HCC). HBV-encoded oncogene X protein (HBx), a key multifunctional regulatory protein, drives viral replication and interferes with several cellular signalling pathways that drive virus-associated hepatocarcinogenesis. This review article provides a comprehensive overview of the role of HBx in modulating the various hallmarks of HCC by supporting tumour initiation, progression, invasion and metastasis. Understanding HBx-mediated dimensions of complexity in driving liver malignancies could provide the key to unlocking novel and repurposed combinatorial therapies to combat HCC.
Funder
Key Program Special Fund XJTLU
Reference169 articles.
1. Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infectionshttps://www.who.int/publications/i/item/9789240027077
2. Can we use HCC risk scores to individualize surveillance in chronic hepatitis B infection?
3. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
4. Recent advancement in hepatitis b virus, epigenetics alterations and related complications;Kgatle,2017
5. Hepatitis B Virus Biology
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献